Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures

Miller, W Greg, Myers, Gary L, Sakurabayashi, Ikunosuke, Bachmann, Lorin M, Caudill, Samuel P, Dziekonski, Andrzej, Edwards, Selvin, Kimberly, Mary M +9 more·2010·Clinical Chemistry

Cited by (383)

Items 301–383 of 383

  1. Poor Performance of LDL-Cholesterol Equations versus Beta Quantification in a Very Large Cohort of Patients with Dyslipidemia
    Martine Paquette, George Thanassoulis, Mark H. Sherman, David W. Blank, Alexis Wilfrid Baass · 2026 · Clinical Chemistry
  2. Update on Investigation and Management of Dyslipidaemias and Cardiovascular Disease Risk
    Kofi Antwi, Ahai Luvai, Paul F. DOWNIE, Ayoob Ghani, Megan Maple, Wycliffe Mbagaya · 2026 · British Journal of Hospital Medicine
  3. Laboratory Diagnostics of Dyslipidemia : From Cholesterol to Apolipoproteins
    Jaana Leiviskä · 2013 · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
  4. Translation: Non-HDL Cholesterol Shows Improved Accuracy for Cardiovascular Risk Score Classification Compared to Direct or Calculated LDL Cholesterol in a Dyslipidemic Population
    Hendrick E. van Deventer, W. Greg Miller, Gary L. Myers, Ikunosuke Sakurabayashi, Lorin M Bachmann, Samuel P. Caudill, Andrzej Dziekoński, Selvin H. Edwards, Mary M. Kimberly, William J. Korzun et al. · 2011 · Laboratory Medicine Online
  5. Evaluation of Non-fasting Serum Triglyceride and Low-density Lipoprotein Cholesterol Levels in Children
    Ayumi Miyazaki, Ayako Oguri, Fukiko Ichida · 2012 · Japanese Society of Pediatric Cardiology and Cardiac Surgery
  6. Comparison of different equations for estimation of low-density lipoprotein (LDL) – cholesterol
    Mehmet Fatih Alpdemir, Medine Alpdemir · 2020 · Turkish Journal of Biochemistry
  7. Clinical sample comparison of eight homogeneous assay kits for high density lipoprotein cholesterol and low density lipoprotein cholesterol
    Yoshiaki Iizuka, Michikuni Ishijima, Takanori Kato · 2012 · 生物試料分析 = Journal of analytical bio-science
  8. U-Shaped Relationship Between Proteinuria and High-Density Lipoprotein Cholesterol: Results of Cross-Sectional and Six Years Cohort Studies (KITCHEN-10)
    Manami Igata, Kei Nakajima · 2022 · Journal of Clinical Medicine Research
  9. TG/HDL, Non-HDL, and TyG index as predictive parameters for CVDs in uncontrolled diabetic patients better than LDL-C and LDL/HDL ratio
    Ahmed Alshawi, Haider Ali Alnaji · 2022 · Research Journal of Pharmacy and Technology
  10. Recomendaciones para la estandarización de la medida de lípidos y lipoproteínas. Recomendación (2018)
    Juan Carlos Vella Ramírez, Enrique Rodríguez‐García, Carlos Romero, Beatriz Candás Estébanez, María José Castro Castro, Teresa Arrobas Velilla, Pilar Calmarza, Margarita Esteban Salán, Miguel Pocoví Mieras, José Puzo · 2018 · Revista del Laboratorio Clínico
  11. Serum high sensitivity C reactive protein and lipid profile in obese students
    Sangeeta B. Trimbake, Shilpa Aditya Pratinidhi, Yash K. Majithia · 2019 · International Journal of Research in Medical Sciences
  12. Comparison of direct and precipitation methods for the estimation of major serum lipoproteins
    J.M. Mulinge, SK Waithaka, S N N Kaggia · 2017 · East African Medical Journal
  13. Retrospective analysis of the cholesterol levels in a European mid-latitude population between 2007 and 2018: controversies and therapeutic implications.
    Davide Ferrari, Andrea Motta, Marta Strollo, Massimo Locatelli · 2020 · Acta bio-medica dell'Ateneo parmense/Acta biomedica
  14. Accuracy of New Equation to Calculate Low-Density Lipoprotein Cholesterol—Reply
    Alan Thomas Remaley, Maureen L. Sampson · 2020 · JAMA Cardiology
  15. Are Caveolin-1 minor alleles more likely to be risk alleles in IR mechanisms in metabolic diseases?
    Faezeh Abaj, Said Abdul Ghafour Saeedy, Khadijeh Mirzaei · 2021 · Research Square
  16. In Reply
    W. Greg Miller, Gary L. Myers, Alan Thomas Remaley · 2011 · Clinical Chemistry
  17. Klinische Befunde und rationelle Differenzialdiagnostik der diabetischen Dyslipidämie
    Arnold von Eckardstein · 2012 · Der Diabetologe
  18. Cardiovascular screening: which populations, what measures of risk?
    Anthony S. Wierzbicki · 2010 · International Journal of Clinical Practice
  19. Present Status of the Standardization of HDL-C, LDL-C, and TG Measurement Values Available in Japan
    Yasuhito Nakajima, Hachiro Yamanishi, Nariaki Matsuura∥ · 2013 · Journal of Clinical Laboratory Analysis
  20. Development of Formulas for Estimation of Cholesterol Levels in Major Serum Lipoproteins Separated by Agarose Gel Electrophoresis
    Somlak Vanavanan, Sirirat Chaloeysup, Kazuhiko Kotani, Pornpen Srisawasdi · 2011 · Journal of Electrophoresis
  21. Serum High Sensitivity CRP (HsCRP) in Psoriasis
    Vaishali Dhat, Dr Mr Sumit Murhe, Alka N. Sontakke · 2014 · International Journal of Medical Research and Review
  22. Biomarker des Lipoproteinstoffwechsels
    Arnold von Eckardstein · 2015 · Cardiovascular Medicine
  23. Erratum: The Relationship Between Low-Density Lipoprotein Cholesterol Levels and the Incidence of Cardiovascular Disease in High-Risk Patients Treated With Pravastatin
    Hiroyuki Daida, Tamio Teramoto, Yasuhisa Kitagawa, Yasuyuki Matsushita, Masahiro Sugihara, on behalf of the APPROACH-J Study Group · 2014 · International Heart Journal
  24. 2. Laboratory Testings for Diagnosis and Management of Dyslipidemia
    Kazuhisa Tsukamoto · 2013 · Nihon Naika Gakkai Zasshi
  25. El Colesterol no-HDL demuestra una mejor exactitud en el score de la clasificación del riesgo cardiovascular comparado con el colesterol LDL, directo o calculado, en una población dislipémica Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated ldl cholesterol in a dyslipidemic population
    Hendrick E. van Deventer, W. Greg Miller, Gary L. Myers, Ikunosuke Sakurabayashi, Lorin M Bachmann, Samuel P. Caudill, Andrzej Dziekoński, Selvin H. Edwards, Mary M. Kimberly, William J. Korzun et al. · 2011
  26. CME-Labor 53/Auflösung : Postanalytik
    Arnold von Eckardstein · 2018 · PubMed
  27. Which of low-density lipoprotein cholesterol estimates can be used in children with type 1 diabetes?
    Jolanta Bugajska, Joanna Berska, Katarzyna Mamica, Karolina Wachacka, Krystyna Sztefko · 2017 · Diagnosis
  28. Association between Serum Ceruloplasmin level and Dyslipidemia: Study in Tertiary care Teaching Hospital
    Vaishali Dhat, Dr Miss Madhura Tinaikar, Alka N. Sontakke · 2013 · International Journal of Medical Research and Review
  29. Changing the Cholesterol-Centric Paradigm for the Assessment of the Proatherogenic Potential of Low-Density Lipoproteins
    Alan Thomas Remaley, Zhihong Yang · 2018 · The Journal of Applied Laboratory Medicine
  30. I. Laboratory Tests of Serum Lipids for General Physician-screening and Diagnostic Procedures of Dyslipidemia
    Satoshi Hirayama · 2017 · Nihon Naika Gakkai Zasshi
  31. Messqualität von „low density lipoprotein cholesterol“
    Annette Masuch, Astrid Petersmann, Nele Friedrich, Matthias A. Nauck · 2018 · Der Diabetologe
  32. Practice of Dyslipidemia in Health Check-up
    Noriaki Kishimoto, Yasuhiro Nishizaki · 2019 · Health Evaluation and Promotion
  33. Analytical discrepancies and their potential impact on biomarkers and precision medicine initiative
    Abdel B Halim · 2019 · Elsevier eBooks
  34. Comparability of estimated and determined LDL cholesterol in hospitalized children
    Katarzyna Mamica, Jolanta Bugajska, Joanna Berska, Krystyna Sztefko · 2019 · Diagnostyka Laboratoryjna
  35. Apolipoproteína B: sus ventajas en el manejo del riesgo cardiovascular aterosclerótico
    Raúl Ignacio Coniglio · 2021 · Redalyc (Universidad Autónoma del Estado de México)
  36. Meeting abstracts from the 2020 UCD School of Medicine Summer Student Research Awards (SSRA 2020)
    2021 · Irish Journal of Medical Science (1971 -)
  37. Triglyceride/low-Density-Lipoprotein Cholesterol (TG/LDL-C) Ratio is the Most Diagnostically Valuable Predictor for Increased Small, Dense LDL in Type 2 Diabetes Patients
    Gen Ouchi, Ichiro Komiya, Shinichiro Taira, Tamio Wakugami, Yusuke Ohya · 2021 · Research Square
  38. Epidemiology
    Anatol Kontush, M. John Chapman · 2011 · Wiley eBooks
  39. LDL and beyond: New emerging LDL biomarkers in lipidology
    2019
  40. Place des marqueurs lipidiques dans la stratification du risque cardiovasculaire : LDL cholestérol, HDL cholestérol, triglycérides, apolipoprotéine B
    Patrice Thérond · 2022 · Revue Francophone des Laboratoires
  41. Correlation of Serum and Salivary Lipids and their Degree of Accuracy among Apparently Healthy Primary School Children aged 5-12 Years in Sokoto, Nigeria
    Taibat A. Raji, Usman Muhammad Sani, Modupe O. Ugege, Ben Onankpa · 2022 · Research Square
  42. Derivation of a Modified Friedewald’s equation for LDL cholesterol estimation in Sub-Himalayan population
    Parmila Dudi, Vishwajeet Vishwajeet, Shashi Ranjan Mani Yadav, Poonam Sharma, Prashant Kumar, Anissa Atif Mirza, Manisha Naithani, Satyavati V. Rana, Bela Goyal · 2022 · Journal of Family Medicine and Primary Care
  43. Hypertriglyceridaemia: a commentary
    Aidan Ryan, William G Simpson, Patrick J. Twomey · 2022 · Journal of Clinical Pathology
  44. Genetic lipid disorders, the APOE gene and Familial Dysbetalipoproteinemia
    Britt E. Heidemann · 2022
  45. Comment on: LDL-C – when to calculate and when to measure?
    Aidan Ryan, Erum Rasheed, Patrick J. Twomey · 2023 · Journal of Clinical Pathology
  46. Comparison of direct low density lipoprotein cholesterol measurement with the Friedewald formula and alternative formulas
    Nilgün Işıksaçan, Cennet Yıldız, Fatma Nihan Turhan Çağlar, Murat Koşer, Pınar Atar, İsmail Bıyık, Dilay Karabulut, Mehmet Ertürk · 2023 · Journal of Clinical Medicine of Kazakhstan
  47. Measurement of Lipids and Lipoproteins
    Marissa Lightbourne, Stephanie T Chung · 2023 · Springer eBooks
  48. Lipoproteins Levels in Rheumatoid Arthritis
    Yousef Ahmed Shaher, Farhan Hussain Ali, Sarah Tareq Abdulazeez · 2023 · Journal of Prevention Diagnosis and Management of Human Diseases
  49. Directly measured homogeneous HDL-Cholesterol in dyslipidaemic specimens: Is variability a cause for concern?
    Rajarshi Sarkar · 2023 · Research Square
  50. Misurazione diretta del colesterolo-LDL e sue possibili conseguenze sulla terapia farmacologica
    Roberto Cemin, Simona Casablanca, Davide Ermacora, Massimo Daves · 2023 · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine
  51. Hematological, Cardiovascular and Oxidative DNA Damage Markers Associated with Heavy Metal Exposure in Electronic Waste (E-Waste) Workers of Bangladesh
    Sarker Masud Parvez, M. Mamun Huda, Masatake Fujimura, Mahbubur M. Rahman, Farjana Jahan, Shaikh Sharif Hasan, Nirupam Aich, Abul Hares, Mohammad Zahirul Islam, Rubhana Raqib et al. · 2024 · SSRN Electronic Journal
  52. Martin’s formula is best to calculate low-density lipoprotein cholesterol
    Fatima Farheen, Sudha Ambiger, Kamarudin Jaalam, S. B. Javali · 2024 · Journal of Laboratory Physicians
  53. Labordiagnostik von Fettstoffwechselstörungen
    Winfried März, Hubert Scharnagl, Marcus Edi Kleber, Günther Silbernagel, Matthias Nauck, Dirk Müller‐Wieland, Arnold von Eckardstein · 2024 · Diabetes aktuell
  54. More precise method of low-density lipoprotein cholesterol estimation for tobacco and electronic cigarette smokers: A cross-sectional study
    Han‐Joon Bae, Hae Won Jung, Seung-Pyo Hong · 2024 · PLoS ONE
  55. Challenges and Future Directions in Lipoprotein Measurement for Atherosclerosis Prevention and Treatment
    Tomokazu Konishi · 2024 · International Journal of Molecular Sciences
  56. The Validation of a Novel, Sex-Specific LDL-Cholesterol Equation and the Friedewald, Sampson-NIH, and Extended-Martin–Hopkins Equations Against Direct Measurement in Korean Adults
    Hyun Suk Yang, Soo‐Nyung Kim, Seungho Lee, Mina Hur · 2025 · Metabolites
  57. A Therapeutic Approach of Chitosan-loaded p-Coumaric Acid Nanoparticles to Alleviate Diabetic Nephropathy in Wistar Rats
    Amalan Venkatesan, Gitanjali Jayaraman, Srinivasan Kulandaivel, Asokan Balakrishnan Ramajayam, Sankar Madhavan, Vijayakumar Natesan, Sung‐Jin Kim · 2025 · Current Pharmaceutical Biotechnology
  58. Calculation formulas for low density lipoprotein cholesterol in cardiological practice: the more, the better?
    Садовников Павел Сергеевич, Victor S. Gurevich · 2025 · Almanac of Clinical Medicine
  59. Discordant Results of Two LDL Cholesterol Homogeneous Methods Explained by Differences in LDL Particle Size Distribution
    Jaeryuk Kim, Eun‐Jung Cho, Hyunki Kim, Sollip Kim, Woochang Lee, Sail Chun, Won‐Ki Min · 2025 · Laboratory Medicine Online
  60. Serum biochemical analytes, COVID-19 and harmonization
    Bedrich Friedecky, J Kratochvíla · 2022 · Klinická biochemie a metabolismus
  61. Pilot study on laboratory sample exchange: Evaluation and key findings
    Oana Roxana Oprea, Diana Ionela Handolescu, Minodora Dobreanu · 2025 · Revista română de medicină de laborator
  62. Calculated Excess-Triglyceride Based on the Friedewald Formula is a Possible Surrogate Marker for the Production of Large Very-Low Density Lipoprotein, A Post-Hoc Analysis of the PROUD48 Study
    Tsutomu Hirano, Yasutaka Takeda, Ichiro Sakuma, Shinya Hiramitsu, Mizuho Okada, Shinichiro Ueda, Masaru Sakurai · 2025 · Journal of Atherosclerosis and Thrombosis
  63. Lipoproteins Levels in Rheumatoid Arthritis
    Yousef Ahmed Shaher, Farhan Hussain Ali, Sarah Tareq Abdulazeez · 2023 · Journal of Prevention Diagnosis and Management of Human Diseases
  64. Direct versus calculated LDL cholesterol: Insights from the Friedewald, Martin–Hopkins, and Sampson approaches in the Indian population
    Roshan Kumar Mahat, Suchismita Panda, Gautam Panda · 2025 · REC CardioClinics
  65. Harmonisation of Low-Density Lipoprotein Cholesterol Results Obtained with Different Direct Methods: A Study Based on an External Quality Assessment Program
    Agnieszka Ćwiklińska, Aleksandra Fijałkowska · 2025 · Journal of Clinical Medicine
  66. 一般健診におけるLDL-C(直接法,F式法)を用いた脂質代謝異常判定の問題点
    竹越 忠美, 木村成里, 岡村 誠太郎, 山本 誠 · 2012
  67. Additional file 1 of An improved method for estimating low LDL-C based on the enhanced Sampson-NIH equation
    Tatiana C. Coverdell, Maureen L. Sampson, Rafael Zubirán, Wolska, Anna, Leslie J. Donato, Meeusen, Jeff W., Jaffe, Allan S., Remaley, Alan T. · 2024 · Figshare
  68. Variability of lipids and apolipoproteins results across platforms may impact cardiovascular risk assessment
    Imola Györfi, Oana Roxana Oprea, Ion Bogdan Mănescu, Minodora Dobreanu · 2026 · Journal of Laboratory Medicine
  69. New Methods for Calculating LDL-Cholesterol and Related Biomarkers of Atherosclerotic Cardiovascular Disease Risk
    Anna T Wolska, Yeganeh Mansourian, Rafael Zubirán, Maureen L. Sampson, Alan Thomas Remaley · 2026 · Current Atherosclerosis Reports
  70. How to properly interpret lipid profile results
    Vladimír Soška · 2025 · Vnitřní lékařství
  71. High-density lipoprotein-related inflammatory ratios and coronary heart disease: A cross-sectional machine learning analysis of NHANES 2009 to 2020
    Yimei Cai, Zhang Guo-xin · 2026 · Medicine
  72. Dosage of lipoproteins for risk management according to guidelines
    Christophe Bonnin, Caroline Fourgeaud, Guillaume Mahé, Khalil Ezzaki, Marc Gras, François Xavier Himpens, Romain Jacquet, Lina Khider, Tristan Mirault, J.N. Poggi et al. · 2026 · Vascular Diseases
  73. When Direct LDL Cholesterol Assays Fail: A Case Series of Analytically Implausible Results
    Sanghyeun Park, Joonsang Yu, Sollip Kim, Woochang Lee, Sail Chun · 2026 · Annals of Laboratory Medicine
  74. Diagnostic Reliability of Medical Test Results as Routinely Reported to Physicians and Patients by Clinical Laboratories
    Mark P. Silverman · 2026 · Open Journal of Applied Sciences
  75. Comparative Evaluation of Machine Learning Models and Conventional Formulas for LDL Cholesterol Estimation
    Bağnu Orhan, Levent Deniz, Cengiz Aydin, İpek Deveci Kocakoç · 2026 · Diagnostics
  76. Biology of HDL: From Structural Heterogeneity to Dysfunctional Remodeling in Cardiovascular Disease and Comorbidities
    Y N Cai, Kehan Li, Huibo Ma, Jianqiang Wu, Yuehong Zheng · 2026 · Antioxidants
  77. Österreichischer Lipidkonsensus 2026
    Florian Kronenberg, Florian Höllerl, Helmut Brath, Gersina Rega‐Kaun, Susanne Greber‐Platzer, Christoph Weiser, Dominic P Klein, Nikolaus Riesenhuber, Christoph J. Binder, Johanna Maria Brix et al. · 2026 · Wiener klinische Wochenschrift
  78. High density lipoproteins and extracellular vesicles—distinct but overlapping circulating particles and their role in atherosclerosis
    Linas Černiauskas, Goda Aleknavičiūtė-Valienė, Skaiste Arbaciauskaite, Nicolas Mytzka, Susann Allelein, Inga Bikulčienė, Dovilė Karčiauskaitė · 2026 · Frontiers in Cardiovascular Medicine
  79. Assessing Analytical Performance and Standardizing Lipid Measurements–Sometimes a Conundrum
    Hubert W. Vesper, Uliana Danilenko, Otoe Sugahara, Sollip Kim, Yeo‐Min Yun, Alicia N. Lyle · 2026 · Annals of Laboratory Medicine
  80. LDL-C equation disagreement as a threshold-integrity flag for orthogonal lipid confirmation
    Ronald Doku, Nana Yaw A. Osafo, John Kwagyan, William M. Southerland · 2026 · Journal of clinical lipidology
  81. Equation Disagreement as a Zero-Cost Uncertainty Signal for LDL-C Classification: An Interpretable Regime-Aware Calibration Model Rescues Misclassification at Treatment Thresholds
    Ronald Doku, Nana Yaw A. Osafo, John Kwagyan, William M. Southerland · 2026 · The Journal of Applied Laboratory Medicine
  82. Apolipoprotein B in cardiovascular risk assessment: beyond traditional lipid markers
    Lingling Li, Yixuan Feng, Xiaoya Li, Zongliang Yu, Changxin Sun, Lanqing Hu, Kaidong Zhou, Xinyi Liu, Yongfang Yuan, Liang Li et al. · 2026 · Frontiers in Cardiovascular Medicine
  83. Hepatoprotective Effect of Nicotinamide Mononucleotide on High‐Fat Diet‐Induced Non‐Alcoholic Fatty Liver Disease in Mice
    Yiwen Zhang, Yafei Wu, Yanhong Wei, Xuan Liu, Xiaocan Lei, Hua Huang, Meixiang Li · 2026 · Food Science & Nutrition